Trachoma
For patient information page click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Egyptian ophthalmia; granular conjunctivitis
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Trachoma is an infectious eye disease, and the leading cause of the world’s preventable blindness.
Causes
Trachoma is caused by the bacteria Chlamydia trachomatis and it is spread by direct contact with eye, nose, and throat secretions from affected individuals, or contact with fomites (inanimate objects), such as towels and/or washcloths, that have had similar contact with these secretions.
Diagnosis
Physical Examination
An eye exam may reveal scarring on the inside of the upper eye lid, redness of the white part of the eyes, and new blood vessel growth into the cornea.
Treatment
Medical Therapy
Antibiotics can prevent long-term complications if used early in the infection. Antibiotics include erythromycin and doxycycline. In certain cases, eyelid surgery may be needed to prevent long-term scarring, which can lead to blindness if not corrected.
Cost-Effectiveness of Therapy
Globally this disease results in an estimated US $2.9 billion in lost productivity every year by affecting 84 million people from active infection and nearly 8 million people, who are visually impaired as a result of this disease.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Historical Perspective
The disease is one of the earliest recorded eye afflictions, having been identified as early as 27 B.C. Today, most victims of trachoma live in underdeveloped and poverty-stricken countries in Africa, the Middle East, and Asia. Rare in the United States, the disease can be treated with antibiotics and prevented with adequate hygiene and education. According to the Centers for Disease Control, “No national or international surveillance [for trachoma] exists. Blindness due to trachoma has been eliminated from the United States. The last cases were found among American Indian populations and in Appalachia.”[1]
In 1913, President Woodrow Wilson signed an act designating funds for the eradication of the disease.[2] By the late 1930s, a number of ophthalmologists reported success in treating trachoma with sulfonamide antibiotics.[3] In 1948, Vincent Tabone (who was later to become the President of Malta) was entrusted with the supervision of a campaign in Malta to treat trachoma using sulfonamide tablets and drops.[4]
Although by the 1950s, trachoma had virtually disappeared from the industrialized world, thanks to improved sanitation and overall living conditions, it continues to plague the developing world. This potentially blinding disease remains endemic in the poorest regions of Africa, Asia, and the Middle East and in some parts of Latin America and Australia. Currently, 8 million people are visually impaired as a result of trachoma, and 84 million suffer from active infection. The people that went through Ellis Island had to be checked for trachoma.
References
- ↑ http://www.cdc.gov/ncidod/dbmd/diseaseinfo/trachoma_t.htm
- ↑ Allen SK, Semba RD. “The trachoma menace in the United States, 1897-1960.” Surv Ophthalmol. 2002 Sep-Oct;47(5):500-9. PMID 12431697.
- ↑ Thygeson P. “The Treatment of Trachoma with Sulfanilamide: A Report of 28 Cases.” Trans Am Ophthalmol Soc. 1939;37:395-403. PMID 16693194.
- ↑ Ophthalmology in Malta, C. Savona Ventura, University of Malta, 2003
Classification
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Pathophysiology
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Pathophysiology
Trachoma is caused by the bacteria Chlamydia trachomatis and it is spread by direct contact with eye, nose, and throat secretions from affected individuals, or contact with fomites (inanimate objects), such as towels and/or washcloths, that have had similar contact with these secretions. Untreated, repeated trachoma infections result in a painful form of permanent blindness when the eyelids turn inward, causing the eyelashes to scratch the cornea. Children are the most susceptible to infection, but the effects are often not felt until adulthood.
References
Causes
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Trachoma is caused by the bacteria Chlamydia trachomatis and it is spread by direct contact with eye, nose, and throat secretions from affected individuals, or contact with fomites (inanimate objects), such as towels and/or washcloths, that have had similar contact with these secretions.
References
Differentiating Trachoma from other Diseases
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Epidemiology and Demographics
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Risk Factors
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Screening
Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
References
Natural History, Complications and Prognosis
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Complications
Untreated, repeated trachoma infections result in a painful form of permanent blindness when the eyelids turn inward, causing the eyelashes to scratch the cornea. Children are the most susceptible to infection, but the effects are often not felt until adulthood.
Prognosis
Early treatment before the development of scarring and lid deformities has an excellent prognosis. If not treated properly with oral antibiotics, the symptoms may escalate and cause blindness, which is the result of ulceration and consequent scarring of the cornea.
References
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
